Revolution Medicines, Inc. (RVMD) Earnings
|
Expand Research on RVMD
| Next EPS Date | 8/6/26 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -13.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/11/26  |
Q126 | N/A | -$1.80 | N/A | N/A | $4.47M | N/A | N/A | N/A | ||
| 2/25/26 | Q425 | -$1.86 | -$1.58 | -$0.28 | N/A | $3.89M | N/A |  | | Details | |
| 11/5/25 | Q325 | -$1.61 | -$1.41 | -$0.20 | N/A | $1.95M | N/A | | | Details | |
| 8/6/25 | Q225 | -$1.31 | -$1.12 | -$0.19 | N/A | $30.59M | N/A | | | Details | |
| 5/7/25 | Q125 | -$1.13 | N/A | N/A | N/A | N/A | N/A | | | Details | |
| 2/26/25 |
Q424 | N/A | -$0.99 | N/A | N/A | $346.15K | = | N/A | N/A | ||
| 11/6/24 | Q324 | -$0.94 | -$0.89 | -$0.05 | N/A | $807.69K | = | | | Details | |
| 8/7/24 | Q224 | -$0.81 | -$0.77 | -$0.04 | N/A | $807.69K | = | | | Details |
